Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/21/2025

Management of Oral Mucosal Lesions

Introduction to Oral Care

  • The American Society of Clinical Oncology recommends implementing a structured approach starting with oral care protocols, pain management, and nutritional support for patients with oral mucosal lesions after chemotherapy 1

Pain Management

  • The European Society for Medical Oncology suggests using 0.5% doxepin mouthwash (evidence level IV) for pain management, with administration of 15 ml, swish for 1 minute, gargle, and spit out, and avoiding eating/drinking for 30 minutes after use 1
  • The American Society of Clinical Oncology recommends using 0.2% morphine mouthwash for patients who received chemoradiation 1
  • Patient-controlled analgesia with morphine is recommended with evidence level II 1
  • Topical anesthetics (e.g., lidocaine) are recommended for short-term relief of mild mucositis pain 2, 3
  • Benzydamine mouthwash can be used for patients receiving moderate-dose radiation therapy (up to 50 Gy) for pain relief, according to the Multinational Association of Supportive Care in Cancer and the European Society for Medical Oncology 4, 2, 1
  • Systemic analgesics, such as NSAIDs and opioids, may be used as needed for pain management (strength of evidence: moderate) 2, 5, 1, 4
  • A stepped approach based on pain severity is suggested, starting with acetaminophen for mild pain, immediate-release oral opioids for moderate pain, and patient-controlled analgesia with morphine for severe pain, as per the National Comprehensive Cancer Network guidelines 6
  • Regular pain assessment using validated instruments should be conducted at least daily to guide appropriate interventions (strength of evidence: high) 2, 5, 7, 4
  • Transdermal fentanyl is recommended for continuous pain control 1

Prevention and Treatment

  • The American Society of Clinical Oncology recommends using GM-CSF mouthwash for prevention in high-dose chemotherapy patients 1
  • Iseganan antimicrobial mouthwash is suggested for prevention and treatment 1
  • Monitoring for fungal infections (especially Candida) and treating promptly with appropriate antifungals if needed is recommended 1
  • Patients with leucopenia have a higher risk for infection 1
  • Chlorhexidine should be avoided for prevention in patients with solid tumors of the head and neck undergoing radiotherapy, as suggested by the European Society for Medical Oncology 2, 4, 1
  • Sucralfate should be avoided for prevention of radiation-induced oral mucositis, according to the American Society of Clinical Oncology and the European Society for Medical Oncology 2, 4, 1

Dietary Recommendations

  • Avoiding irritating foods (spicy, acidic, hot, raw, or crusty foods) is recommended for patients with oral mucosal lesions after chemotherapy 1
  • Individualized nutritional counseling and oral nutritional supplements (ONS) are critical components of treatment to prevent weight loss and treatment interruptions, as recommended by the American Society for Parenteral and Enteral Nutrition 6
  • For severe cases (Grade 3-4), consider enteral nutrition (EN) via nasogastric tube or percutaneous endoscopic gastrostomy (PEG), with PEG associated with lower risk of tube dislodgement compared to nasogastric tubes, according to the European Society for Clinical Nutrition and Metabolism 6
  • Parenteral nutrition (PN) should only be used if oral/enteral nutrition is not possible, as stated by the American Society for Parenteral and Enteral Nutrition 6
  • Early enteral nutrition via feeding tube should be considered for patients unable to maintain oral intake (strength of evidence: high) 2, 5, 8, 1
  • Maintain adequate hydration throughout treatment, and monitor for secondary infections, treating promptly with appropriate antifungals if needed, as recommended by the Centers for Disease Control and Prevention 6
  • Aggressive hydration is recommended for patients with severe mucositis 1
  • A liquid diet may be necessary for patients with Grade 3 mucositis (WHO scale) 1, 2, 5, 4

Oral Hygiene and Assessment

  • Non-medicated saline mouth rinses 4-6 times daily can help with oral mucositis management, as suggested by the European Society for Medical Oncology 4, 1, 2, 5
  • A soft toothbrush that is replaced regularly can help prevent oral mucositis, as recommended by the American Dental Association and suggested by the National Comprehensive Cancer Network 4, 1, 2, 5
  • Patients using magic mouthwash should maintain meticulous oral hygiene, use a soft toothbrush, avoid alcohol-based mouth rinses, stay well-hydrated, and avoid irritating foods, as advised by the National Comprehensive Cancer Network 1
  • Magic mouthwash should be administered every 4-6 hours, with typical administration involving 15 ml of solution, swishing for approximately 1 minute, gargling, and then spitting out, and avoiding eating or drinking for 30 minutes after use, as recommended by the Multinational Association of Supportive Care in Cancer 1
  • Regular assessment for early intervention, and maintenance of swallowing function with supervised exercises, are crucial for patients with dysphagia, as recommended by the American Speech-Language-Hearing Association 6
  • The WHO Oral Mucositis Scale is used to assess the severity of oral mucositis, with grades ranging from 1 (soreness/erythema) to 4 (alimentation not possible) 2, 5, 4, 1
  • Regular inspection of oral mucosa is recommended to monitor for mucositis development 2, 5, 4
  • Consider temporary dose reduction or treatment interruption for severe mucositis that doesn't respond to supportive care, as stated by the National Comprehensive Cancer Network 6
  • Modifying cancer treatment may be necessary to prevent complications in severe cases 2, 5, 1